Hepatocellular Carcinoma Clinical Trials in Louisville, Kentucky

3 studies are recruiting for hepatocellular carcinoma in Louisville, Kentucky right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Adjuvant IP-001 Treatment for HCC Patients Following Surgical Resection and Ablation or Ablation Alone

    The purpose of this study is to evaluate the safety and efficacy of administration of intratumoral IP-001 injection at different dosages (volume and concentration) following local microwave ablation (MWA) or surgical resection and ablation in patients with hepatocellular carcinoma (HCC).

    Stage
    Phase 2
    Ages
    18 and older
    Site
    University of Louisville, Louisville, Kentucky
    Run by
    Robert C. Martin

    See if you can join NCT06526338 on ClinicalTrials.gov

  2. A Study of ZW251 in Participants With Advanced Solid Tumors

    The purpose of this study is to find out if ZW251, an antibody-drug conjugate targeting glypican-3 (GPC3), is safe and can treat participants with advanced cancers, including hepatocellular carcinoma (HCC), squamous cell non-small cell lung cancer (NSCLC), or germ cell tumors (GCT).

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Norton Cancer Institute, Louisville, Kentucky
    Locations
    25 in total
    Run by
    Zymeworks BC Inc.

    See if you can join NCT07164313 on ClinicalTrials.gov

  3. A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)

    Hepatocellular carcinoma (HCC) is a common cancer worldwide and a leading cause of cancer-related death. The majority of participants first presenting with HCC have advanced unresectable or metastatic disease. The purpose of this study is to evaluate the optimized dose, adverse events, and efficacy…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Norton Cancer Institute /ID# 260775, Louisville, Kentucky
    Locations
    37 in total
    Run by
    AbbVie

    See if you can join NCT06109272 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.